Gabbi, a Portland, Ore.-based startup constructing a software to assist ladies assess their threat for breast most cancers, raised $4.4 million.
Gabbi’s breast most cancers threat calculator can also be designed to suggest a well being motion plan. The corporate goals to launch its product to start with of 2023 as a profit accessible by means of employers, in keeping with an announcement Friday saying the funding.
The brand new money builds on $1 million in pre-seed funding raised in June 2021 and can go towards creating the product and rising the 8-person crew.
“Everybody ought to have the instruments that enable them to know their threat and get entry to the suitable care,” mentioned Gabbi CEO and founder Kaitlin Christine within the assertion.
Christine beforehand held a enterprise growth function at genetic testing firm Myriad Genetics and was motivated to discovered Gabbi after private experiences with breast most cancers. The corporate is called for her mom, Lise Gabrielle Clark, who carried a lethal mutation within the breast most cancers gene BRCA1 and died from the illness.
Christine additionally carries the mutation, which confers a really excessive threat for breast most cancers. That led to a harrowing medical expertise, culminating in a prophylactic double mastectomy at age 24.
Gabbi’s prediction mannequin “is constructed off of one of many largest and most numerous declare units on the earth,” in keeping with an announcement. Christine beforehand advised Startup that the software was being developed with knowledge accessible by means of an insurance coverage firm partnership.
A number of analysis establishments have constructed breast most cancers threat calculators, together with the U.S. Nationwide Most cancers Institute, which supplies a Breast Most cancers Threat Evaluation Software for the general public. The Peter MacCallum Most cancers Centre in Victoria, Australia, constructed iPrevent, which additionally supplies customized breast most cancers screening and prevention data.
CRA Well being, which was acquired by Volpara Well being final 12 months, additionally supplies breast most cancers threat evaluation, however its software is geared extra towards clinicians.
The brand new funding spherical was led by Bread and Butter Ventures, with participation from Feminine Founders Fund, WR Hambrecht, Phoenix Rising, Claridge Ventures Advisors VC, Coyote Ventures, Gaingels and particular person buyers together with David Kidder, Sarah Jones Simmer and Naseem Sayani.